Dave Boucher obtained his PhD in Pharmacology from the University of Sherbrooke (Sherbrooke, QC, Canada) and after a short PostDoc in San Diego (CA, USA), joined Dr Kate Schroder’s group in 2014. His research focuses on how proteases are involved in immune and cell death signalling in health and disease. He is interested in understanding how proteases are activated, how they recognize particular substrates and how substrate proteolysis influences specific signalling pathways. Ultimately, Dave would like to use this knowledge to develop new pharmacological drugs.

Dave has a particular crush on caspases, a very appealing family of proteases. He is inspired by good science and excited about making discoveries. He enjoys a good chat about exciting hypotheses and papers pitfalls around a good coffee (or a tasty beer).